Saniona’s CEO to BioStock: “Our development pipeline is stronger than ever”

Saniona released its year-end report last week, with CEO Thomas Feldthus emphasizing the robustness of the development candidates, especially noting advancements in the epilepsy pipeline. We caught up with Feldthus to gain insights into the company’s plans ahead.

Read the full interview with Thomas Feldthus at biostock.se:

https://www.biostock.se/en/2024/03/sanionas-ceo-our-development-pipeline-is-stronger-than-ever/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/